Cognition Therapeutics, Inc.
CGTX
$1.01
-$0.03-2.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 49.16% | 41.21% | 30.86% | 18.34% | -6.15% |
| Total Depreciation and Amortization | -0.81% | -0.79% | -14.29% | -8.81% | -3.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -41.07% | -40.66% | -46.03% | -49.49% | -43.35% |
| Change in Net Operating Assets | -333.81% | -129.27% | -368.40% | -201.68% | -118.83% |
| Cash from Operations | 42.46% | 34.89% | 13.65% | -15.60% | -34.45% |
| Capital Expenditure | -1,900.00% | -- | -- | 96.97% | 98.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,000.00% | 325.00% | 325.00% | 96.97% | 98.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 44.34% | 48.75% | 52.23% | 34.44% | 17.93% |
| Issuance of Common Stock | 187.21% | 140.60% | 48.00% | 202.27% | -7.63% |
| Repurchase of Common Stock | 66.74% | 68.06% | 82.61% | 90.77% | -576.56% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -68.92% | -68.92% | -- | 100.00% |
| Cash from Financing | 197.27% | 172.31% | 55.19% | 223.78% | -3.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 236.69% | 181.11% | 344.07% | 262.55% | -96.10% |